Final results from a phase II evaluation of lapatinib (L) and bevacizumab (B) in HER2-overexpressing metastatic breast cancer (MBC) Meeting Abstract


Authors: Dickler, M.; Franco, S.; Stopeck, A.; Ma, W.; Nulsen, B.; Lyandres, J.; Melisko, M.; Lahiri, S.; Arbushites, M.; Koehler, M.; Rugo, H. S.
Abstract Title: Final results from a phase II evaluation of lapatinib (L) and bevacizumab (B) in HER2-overexpressing metastatic breast cancer (MBC)
Meeting Title: 31st Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 69
Issue: 2 Suppl.
Meeting Dates: 2008 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2009-01-15
Start Page: 242S
Language: English
ACCESSION: ISI:000262583201151
PROVIDER: wos
DOI: 10.1158/0008-5472.SABCS-3133
Notes: --- - Meeting Abstract: 3133 - Suppl. S - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maura N Dickler
    263 Dickler
  2. Weining Ma
    40 Ma
  3. Benjamin Francis Nulsen
    8 Nulsen